DALLIO, MARCELLO
 Distribuzione geografica
Continente #
EU - Europa 261
NA - Nord America 254
AS - Asia 71
SA - Sud America 5
AF - Africa 3
OC - Oceania 3
Totale 597
Nazione #
US - Stati Uniti d'America 250
IE - Irlanda 128
IT - Italia 93
SG - Singapore 32
CN - Cina 29
DE - Germania 15
FR - Francia 8
FI - Finlandia 6
IN - India 4
AT - Austria 3
AU - Australia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
KZ - Kazakistan 3
PE - Perù 3
BR - Brasile 2
CA - Canada 2
LT - Lituania 2
MX - Messico 2
NL - Olanda 2
BE - Belgio 1
HK - Hong Kong 1
JP - Giappone 1
PK - Pakistan 1
Totale 597
Città #
Dublin 126
Chandler 56
New York 42
Naples 38
Boardman 22
Beijing 16
Singapore 16
Bremen 12
Boydton 10
Cambridge 10
Princeton 9
Ashburn 8
Roxbury 8
Aversa 7
Paris 7
Lappeenranta 5
Astana 3
Bisaccia 3
Brno 3
Caserta 3
Changsha 3
Cusco 3
Houston 3
Hyderabad 3
Melbourne 3
Minya 3
Rome 3
Taiyuan 3
Vienna 3
Amsterdam 2
Casoria 2
Castellammare di Stabia 2
Des Moines 2
Kaunas 2
Mexico City 2
Munich 2
Ottaviano 2
São Paulo 2
Turin 2
West Jordan 2
Bacoli 1
Brusciano 1
Brussels 1
Cellole 1
Central 1
Grazzanise 1
Helsinki 1
Hiroshima 1
Maletto 1
Milan 1
Newark 1
Nola 1
Pomezia 1
Pune 1
Rende 1
San Lazzaro di Savena 1
Trentola-Ducenta 1
Vibo Valentia 1
Totale 471
Nome #
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 60
The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown 40
Integrating Silybin and Sirtuin Related Pathways in Steatosis-Related Liver Diseases 40
PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial 39
Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study 38
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab 38
Inflammatory Bowel Diseases: The Role of Gut Microbiota 37
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 34
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 33
How immunotherapy has changed the continuum of care in hepatocellular carcinoma 33
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 30
Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology 29
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 28
Urinary volatile Organic compounds in non-alcoholic fatty liver disease (NAFLD), type two diabetes mellitus (T2DM) and NAFLD-T2DM coexistence 27
The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications 25
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials 14
Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma 13
Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements 13
Intestinal pseudo-obstruction as systemic lupus erythematosus complication: is it time to reconsider the role of surgery? A case report of a tailored multidisciplinary managed 44-year-old male patient 13
Is it time to reconsider the MRP6 role in bile secretion and LPAC genetic signature? 10
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 8
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women 8
Predicting de‐novo portal vein thrombosis after HCV eradication: A long‐term competing risk analysis in the ongoing PITER cohort 8
Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications 7
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis 6
The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease 5
Systemic Oxidative Balance Reflects the Liver Disease Progression Status for Primary Biliary Cholangitis (Pbc): The Narcissus Fountain 5
The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition 3
Totale 644
Categoria #
all - tutte 3.526
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.526


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202255 0 0 0 0 0 10 2 1 1 7 15 19
2022/2023289 16 4 9 18 53 18 0 17 134 6 6 8
2023/2024294 13 5 8 18 37 57 11 0 21 28 31 65
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 644